176 related articles for article (PubMed ID: 35084585)
1. Long-term management of recurrent papillary thyroid carcinoma treated with lenvatinib for over 5 years: a case report.
Imai T; Kobayashi H; Senaha T; Imaizumi T; Murata Y
Surg Case Rep; 2022 Jan; 8(1):21. PubMed ID: 35084585
[TBL] [Abstract][Full Text] [Related]
2. Response to Lenvatinib in Children with Papillary Thyroid Carcinoma.
Mahajan P; Dawrant J; Kheradpour A; Quintanilla NM; Lopez ME; Orth RC; Athanassaki I; Venkatramani R
Thyroid; 2018 Nov; 28(11):1450-1454. PubMed ID: 30226445
[TBL] [Abstract][Full Text] [Related]
3. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
[TBL] [Abstract][Full Text] [Related]
4. Successful recovery from a subclavicular ulcer caused by lenvatinib for thyroid cancer: a case report.
Kitamura M; Hayashi T; Suzuki C; Hirano S; Tateya I; Kishimoto Y; Omori K
World J Surg Oncol; 2017 Jan; 15(1):24. PubMed ID: 28088233
[TBL] [Abstract][Full Text] [Related]
5. Control of Lung Metastases and Colon Polyposis with Lenvatinib Therapy in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma and an
Ito Y; Ishikawa H; Kihara M; Hirokawa M; Kiyota N; Kasahara T; Miyauchi A
Thyroid; 2019 Oct; 29(10):1511-1517. PubMed ID: 31317827
[No Abstract] [Full Text] [Related]
6. Pancreatic metastasis arising from a BRAF(V600E)-positive papillary thyroid cancer: the role of endoscopic ultrasound-guided biopsy and response to sorafenib therapy.
Alzahrani AS; AlQaraawi A; Al Sohaibani F; Almanea H; Abalkhail H
Thyroid; 2012 May; 22(5):536-41. PubMed ID: 22435913
[TBL] [Abstract][Full Text] [Related]
7. Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma.
Takinami M; Yokota T
Case Rep Oncol; 2020; 13(2):522-527. PubMed ID: 32518548
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case report.
Tori M; Shimo T
BMC Cancer; 2018 Jun; 18(1):698. PubMed ID: 29954369
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria.
Goto H; Kiyota N; Otsuki N; Imamura Y; Chayahara N; Suto H; Nagatani Y; Toyoda M; Mukohara T; Nibu KI; Kasahara T; Ito Y; Miya A; Hirokawa M; Miyauchi A; Minami H
Auris Nasus Larynx; 2018 Dec; 45(6):1249-1252. PubMed ID: 29779695
[TBL] [Abstract][Full Text] [Related]
10. Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report.
Yamazaki H; Masudo K; Kanada S; Inayama Y; Hayashi H; Fujii Y; Rino Y
Surg Case Rep; 2023 Mar; 9(1):38. PubMed ID: 36920674
[TBL] [Abstract][Full Text] [Related]
11. Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case report.
Toda S; Yamamoto Y; Ookubo Y; Hayashi H; Tsunematsu T; Kadoya M; Masudo K; Iwasaki H
Gland Surg; 2023 Oct; 12(10):1441-1448. PubMed ID: 38021198
[TBL] [Abstract][Full Text] [Related]
12. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma.
Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Choe JH; Kim JH; Kim JS
Thyroid; 2011 Sep; 21(9):1027-31. PubMed ID: 21834676
[TBL] [Abstract][Full Text] [Related]
13. [Prospective analysis of the risk factors and clinical indications of dissection of lymph node posterior to right recurrent laryngeal nerve in 283 cases of papillary thyroid carcinoma].
Zhang P; Zhang B; Bu J; Liu Y; Zhang W
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):109-14. PubMed ID: 24796458
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Long-Term Survival of Anaplastic Transformation of Thyroid Cancer in Lymph Node Metastasis Due to Radiation Therapy and Lenvatinib].
Masuda G; Hori T; Tani N; Sakimura C; Teramura K; Tendo M; Nakata B; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2021 Jan; 48(1):148-150. PubMed ID: 33468750
[TBL] [Abstract][Full Text] [Related]
15. [Prediction and investigation of the potential risk factors for the upper mediastinal metastasis of papillary thyroid carcinoma].
Liu Y; Xu SY; Liu K; Wang XL; Liu SY; Xu ZG; Liu J
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):477-483. PubMed ID: 33902211
[No Abstract] [Full Text] [Related]
16. Multiple Simultaneous Rare Distant Metastases as the Initial Presentation of Papillary Thyroid Carcinoma: A Case Report.
Yang J; Ma Y; Gong Y; Gong R; Li Z; Zhu J
Front Endocrinol (Lausanne); 2019; 10():759. PubMed ID: 31781034
[TBL] [Abstract][Full Text] [Related]
17. Rare distant metastases to pancreas, liver, and lung as initial presentation of mixed tall cell and columnar cell variants of papillary thyroid cancer.
Harper C; Michael J; Rahmeh T; Munro V
Endocrinol Diabetes Metab Case Rep; 2022 Nov; 2022():. PubMed ID: 36511454
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of locally advanced papillary thyroid carcinoma after response to lenvatinib: A case report.
Tsuboi M; Takizawa H; Aoyama M; Tangoku A
Int J Surg Case Rep; 2017; 41():89-92. PubMed ID: 29055877
[TBL] [Abstract][Full Text] [Related]
19. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
20. Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report.
Toda S; Iwasaki H; Murayama D; Isoda M; Nakayama H; Suganuma N; Masudo K
J Med Case Rep; 2021 Nov; 15(1):556. PubMed ID: 34763724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
